Nephros (NEPH) Gross Profit Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.53% |
| Dec 31, 2025 | 16.22% |
| Sep 30, 2025 | 18.93% |
| Jun 30, 2025 | 25.58% |
| Mar 31, 2025 | 16.17% |
| Dec 31, 2024 | 5.43% |
| Sep 30, 2024 | 3.39% |
| Jun 30, 2024 | 6.94% |
| Mar 31, 2024 | 16.99% |
| Dec 31, 2023 | 16.20% |
| Sep 30, 2023 | 18.17% |
| Jun 30, 2023 | 20.16% |
| Mar 31, 2023 | 35.22% |
| Dec 31, 2022 | 13.88% |
| Sep 30, 2022 | 7.45% |
| Jun 30, 2022 | 21.96% |
| Mar 31, 2022 | 18.27% |
| Dec 31, 2021 | 30.68% |
| Sep 30, 2021 | 33.90% |
| Jun 30, 2021 | 33.83% |
| Mar 31, 2021 | 40.01% |
| Dec 31, 2020 | 38.77% |
| Sep 30, 2020 | 49.14% |
| Jun 30, 2020 | 20.11% |
| Mar 31, 2020 | 39.52% |
| Dec 31, 2019 | 54.48% |
| Sep 30, 2019 | 41.92% |
| Jun 30, 2019 | 35.53% |
| Mar 31, 2019 | 22.15% |
| Dec 31, 2018 | 77.03% |
| Sep 30, 2018 | 32.97% |
| Jun 30, 2018 | 18.92% |
| Mar 31, 2018 | 7.52% |
| Dec 31, 2017 | 58.41% |
| Sep 30, 2017 | 5.19% |
| Jun 30, 2017 | 14.13% |
| Mar 31, 2017 | 7.91% |
| Dec 31, 2016 | 19.71% |
| Sep 30, 2016 | 0.45% |
| Jun 30, 2016 | 7.91% |
| Mar 31, 2016 | 8.19% |
| Dec 31, 2015 | 11.47% |
| Sep 30, 2015 | -11.34% |
| Jun 30, 2015 | 4.89% |